Bahman Emami

Active 1978–2024

54
Papers
18,158
Citations
50
h-index
53
i10-index

Citations

Citations per year for Bahman Emami1980: 1 citations1981: 1 citations1983: 1 citations1984: 5 citations1985: 1 citations1986: 5 citations1987: 6 citations1988: 5 citations1989: 6 citations1990: 8 citations1991: 14 citations1992: 17 citations1993: 31 citations1994: 27 citations1995: 40 citations1996: 43 citations1997: 54 citations1998: 58 citations1999: 69 citations2000: 88 citations2001: 110 citations2002: 130 citations2003: 128 citations2004: 126 citations2005: 164 citations2006: 113 citations2007: 147 citations2008: 104 citations2009: 117 citations2010: 163 citations2011: 106 citations2012: 101 citations2013: 84 citations2014: 70 citations2015: 81 citations2016: 71 citations2017: 69 citations2018: 41 citations2019: 249 citations2020: 215 citations2021: 173 citations2022: 108 citations2023: 77 citations2024: 145 citations2025: 43 citations2026: 1 citations1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,333 citing papers, 31.8% of this breakdownNetherlands: 290 citing papers, 6.9% of this breakdownGermany: 289 citing papers, 6.9% of this breakdownChina: 251 citing papers, 6% of this breakdownUnited Kingdom: 230 citing papers, 5.5% of this breakdownCanada: 210 citing papers, 5% of this breakdownItaly: 169 citing papers, 4% of this breakdownJapan: 165 citing papers, 3.9% of this breakdownFrance: 140 citing papers, 3.3% of this breakdownBelgium: 105 citing papers, 2.5% of this breakdownSwitzerland: 100 citing papers, 2.4% of this breakdownAustralia: 94 citing papers, 2.2% of this breakdown
0%31.8%Other 19.6%

Fields

  • Medicine73.8%
  • Physics and Astronomy13.9%
  • Biochemistry, Genetics and Molecular Biology5.7%
  • Engineering4.1%
  • Computer Science0.7%
  • Materials Science0.4%
  • Other1.4%

Topics

  • Advanced Radiotherapy Techniques10.2%
  • Lung Cancer Diagnosis and Treatment6.8%
  • Effects of Radiation Exposure5.6%
  • Head and Neck Cancer Studies5.2%
  • Esophageal Cancer Research and Treatment4.2%
  • Radiation Therapy and Dosimetry4%
  • Other64%

Coauthors

All papers

Open in search
  1. Tolerance of normal tissue to therapeutic irradiation

    Authors: , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1991 cited by 4,472

  2. Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus

    Authors: , , , , , , , , , - New England Journal of Medicine 1992 cited by 2,121

  3. Fitting of normal tissue tolerance data to an analytic function

    Authors: , , , - International Journal of Radiation Oncology*Biology*Physics 1991 cited by 1,255

  4. Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death

    Authors: , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2019 cited by 187

  5. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines

    Authors: , , , , , , , , , , , , , , , , , , - Radiotherapy and Oncology 2003 cited by 680

  6. Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

    Authors: , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1999 cited by 1,217

  7. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.

    Authors: , , , , , , , , , - Journal of Clinical Oncology 1997 cited by 744

  8. American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2008 cited by 538

  9. Tolerance of Normal Tissue to Therapeutic Radiation

    Authors: - Reports of Radiotherapy and Oncology 2013 cited by 456

  10. Adaptive Radiotherapy for Head and Neck Cancer

    Authors: , , , , , - Technology in Cancer Research & Treatment 2016 cited by 84

  11. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: A population-based study

    Authors: , , - International Journal of Radiation Oncology*Biology*Physics 2003 cited by 375

  12. Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer

    Authors: , , , , , , , , , , - CHEST Journal 2000 cited by 632

  13. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials

    Authors: , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1999 cited by 115

  14. Physiological mechanisms in hyperthermia: A review

    Authors: , - International Journal of Radiation Oncology*Biology*Physics 1984 cited by 111

  15. Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments

    Authors: , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2021 cited by 28

  16. Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinoma

    Authors: , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2005 cited by 446

  17. Increasing Tumor Volume is Predictive of Poor Overall and Progression-Free Survival: Secondary Analysis of the Radiation Therapy Oncology Group 93-11 Phase I-II Radiation Dose-Escalation Study in Patients with Inoperable Non–Small-Cell Lung Cancer

    Authors: , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2007 cited by 113

  18. Randomized Trial of Hyperfractionation Versus Conventional Fractionation in T2 Squamous Cell Carcinoma of the Vocal Cord (RTOG 9512)

    Authors: , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2014 cited by 91

  19. Three-dimensional treatment planning for lung cancer

    Authors: , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1991 cited by 86

  20. Interruptions of high-dose radiation therapy decrease longterm survival of favorable patients with unresectable nonsmall cell carcinoma of the lung: analysis of 1244 cases from 3 radiation therapy oncology group (RTOG) trials

    Authors: , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1993 cited by 228

  21. Randomized Phase III Study Comparing Irradiation and Hyperthermia with Irradiation Alone in Superficial Measurable Tumors

    Authors: , , , , , - American Journal of Clinical Oncology 1991 cited by 171

  22. RTOG quality assurance guidelines for clinical trials using hyperthermia

    Authors: , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1990 cited by 133

  23. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma

    Authors: , , - International Journal of Radiation Oncology*Biology*Physics 2003 cited by 124

  24. Second primary cancers in patients with laryngeal cancer: A population-based study

    Authors: , , , - International Journal of Radiation Oncology*Biology*Physics 2003 cited by 103